Xylo Technologies Ltd.
NASDAQ: MDGS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Liron Carmel
- Employees
- 38
- Headquarters
- Tel Aviv, Israel
- IPO year
- 2015
- Market cap
- $178.9M
- Website
- https://www.medigus.com
Loading MDGS…
Loading profile data…Frequently asked questions about MDGS
What does Xylo Technologies Ltd. (MDGS) do?
Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel. The company's diverse operations are organized into several distinct segments, including Corporate, E-commerce, Online Adve...
Where does MDGS trade?
Xylo Technologies Ltd. (MDGS) trades on the NASDAQ Capital Market.
What sector is MDGS in?
Xylo Technologies Ltd. (MDGS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Xylo Technologies Ltd.?
Liron Carmel is the chief executive officer of Xylo Technologies Ltd. (MDGS).
Where is Xylo Technologies Ltd. headquartered?
Xylo Technologies Ltd. is headquartered in Israel.
Does MDGS pay a dividend?
Yes — Xylo Technologies Ltd. (MDGS) paid a trailing twelve-month dividend of USD 0.85 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MDGS go public?
Xylo Technologies Ltd. (MDGS) completed its initial public offering in 2015.
Is MDGS an ADR?
Yes — MDGS is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Xylo Technologies Ltd. reporting and dividends follow the underlying issuer.